Featured Insights

1. Addressing Market Access Challenges As CGTs Expand To Larger Patient Populations 5/1/2025

   Navigating market access for advanced therapies requires new strategies. Explore ways to boost payer understanding, innovate pricing, and adapt treatment settings as these therapies expand.

2. The Future Promise Of Advanced Therapies In Ophthalmology 3/17/2025

   Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.

3. Navigating Patient Access Challenges When Bringing Your CGT Product To Market 2/24/2025

   Bringing cell and gene therapies to market requires more than scientific breakthroughs; manufacturers must navigate complex patient access challenges to ensure these innovations reach those in need.

4. Optimizing The Channel Strategy To Expand Patient Access 1/17/2025

   Patient access depends on a well-planned channel strategy. Explore key considerations for optimizing distribution, logistics, and patient support in the evolving cell and gene therapy landscape.

5. Insights From The FDA's New FAQ 12/17/2024

   The FDA's new FAQ offers crucial insights into best practices, from regulatory meetings to quality control and preclinical studies. Dive in for expert guidance.

6. Beyond Definitions: The Intricacies Of Cell Therapy Categorization 11/11/2024

   Understanding the intricacies of cell and gene therapy naming conventions can be confusing but necessary for effectively navigating the development pathway to bring these advanced therapies to market.

7. ThinkLive Cell And Gene Therapy Summit 2024 10/21/2024

   Discover key takeaways from the inaugural ThinkLive Cell and Gene Therapy Summit held on May 14-15, 2024, featuring over 30 speakers discussing healthcare innovation.

8. Leveraging Past Learnings For Future-Focused Solutions To Clinical Manufacturing 9/23/2024

   Hear valuable insights in this panel discussion on the future of clinical manufacturing, including regulatory hurdles, industry-regulator partnerships, and strategies for successful drug development.

9. Takeaways From Cencora's Inaugural Cell And Gene Therapy Summit 8/14/2024

   Collaboration, communication, and competition are key to advancing cell and gene therapy. Experts share insights from Cencora's inaugural CGT summit.

10. EMA Adopts Collaborative Approach With ATMP Guideline Update 7/17/2024

    The EMA has taken a collaborative approach with its updated ATMP guideline, aiming to streamline development and clarify regulatory expectations for cell and gene therapies across Europe's landscape.